AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry

RecruitingNAAges 18 Years - anyAllSensimed AG
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

While elevated intraocular pressure (IOP) is no longer part of the definition of glaucoma it remains the sole proven modifiable risk factor for the onset and progression of glaucoma. IOP is known to vary with the time of day as well as with daily activities. The importance of the nycthemeral IOP pattern for successful management of glaucoma has been well documented, especially for patients who experience visual loss despite apparently normal and/or controlled IOP during office hours. The current way of assessing nycthemeral IOP fluctuation is to perform repeated discrete tonometry measurements, once per hour in the best cases. Since its development in the 50s, Goldmann applanation tonometry (GAT) has remained the gold standard method for measuring IOP, despite its limitations. However, tonometry may be an imperfect method for measuring changes in IOP because it allows only snapshot and

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Informed Consent * A clinical diagnosis of primary open angle glaucoma (POAG), including normal tension glaucoma (NTG), for OAG patients * A clinical diagnosis of OHT, for OHT patients * For all patients: Open angles on gonioscopy Aged โ‰ฅ 18 years, either gender Both central corneal radii (CCR) between 7.3mm (46.23D) and 8.05mm (41.93D), with a maximum difference of 2D between the 2 radii in the study eye Central corneal thickness (CCT) between 490ยตm and 600ยตm in the study eye Exclusion Criteria: * Ocular pathology (other than glaucoma or OHT) * Previous glaucoma, cataract or refractive laser/surgery * Corneal or conjunctival abnormality, precluding contact lens adaptation * Insufficiency of lacrimal secretion * Subjects with allergy to corneal anesthetic * Subjects with contraindications for silicone contact lens wear * Subjects with contraindications for Diamox or Latanoprost or Timolol * Skin irritations, skin eczema or other indications against the wearing of adhesive patches * Subjects unable or unwilling to comply with the study procedures * Subjects lacking the capacity to consent (vulnerable persons) * Subjects with history of cardiac failure, treated cardiopathy or renal failure * Subjects with known cognitive disorders * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant, * Participation in another study with investigational drug within the 30 days preceding and during the present study, * Enrolment of the investigator, his/her family members, employees and other dependent persons.
๐Ÿ’Š

What it tests

  • Goldfish (GF)
๐Ÿ“

Where

1 site
Clinique Montchoisi
Lausanne, Switzerland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy